Notice of intent to sole source - sterility media supplies thermo fisher
Closed Special Notice Posted
- Solicitation number
- 87978
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- Place of performance
- Atlanta, Georgia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice indicating their intent to award a sole source firm fixed price purchase order to Thermo Fisher Scientific for specific sterility media supplies. The CDC requires these products for their Influenza Division sterility media protocol, and Thermo Fisher is the only vendor that can provide the entire required list with the necessary ingredients.
The purpose of this Special Notice is to inform interested parties of the CDC's intent to sole source this requirement under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). While the CDC is open to receiving capability statements or proposals from other interested vendors, they reserve the right to sole source this contract. Any quotations or responses must be submitted to the contract specialist by 5:00 PM EDT on August 2, 2024, and the government will consider all submissions received within 15 days in determining whether to conduct a competitive procurement.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Thermo Fisher for the products listed in the attachment.
The products are all available from the contractor and are available using pre-qualified materials. Although companies other than Thermo Fisher Scientific create the products or re-sell the products, they do not carry everything needed by the CDC with the same formula required by the CDC. Some vendors carry bulk containers of the items; however, the recipes are slightly different and will not work for the CDC processes. They have not been approved by the Influenza Division sterility media protocol. The reagents used from Fisher to characterize influenza viruses have been tested and qualified and are regulated by the CDC’s standard operating procedures (SOP) and quality protocols. There is no other vendor who can provide the entire required list with the required ingredients. Additionally, the work needed to achieve CDC’s goals requires all products listed at the same time which is more difficult to regulate when ordering from multiple vendors. Sole sourcing all products from Fisher allows consistent quality and expiry dates across multiple products. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Jennifer Gartzke at xuy7@cdc.gov by 5:00 PM EDT August 2, 2024.
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source_87978_Sterility Media.doc | DOC document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity